Multidimensional flow cytometry immunophenotyping of hematologic malignancy

Guido Pagnucco, Laura Vanelli, Francesco Gervasi

Research output: Contribution to journalArticlepeer-review


Immunophenotyping of hematologic malignancies represents one of the most relevant clinical applications of flow cytometry. Classically, leukemic/lymphomatous cells have been considered to reflect the immunophenotypic characteristics of different precursors and mature healthy cells blocked at certain differentiation stages. Recently, accumulating evidence has shown that neoplastic cells display several aberrant phenotypic patterns. These aberrant phenotypes are believed to reflect genetic abnormalities present in pathologic cells, and recent data have shown that at least in acute leukemias, myelodysplastic syndromes, chronic lymphoproliferative disorders, and plasma cell dyscrasias, they may be present in almost all patients. The aim of this work is to review recent advances in flow cytometry and the role of gating strategies more useful in the identification and characterization of neoplastic cells of different hematologic malignancies.

Original languageEnglish
Pages (from-to)313-321
Number of pages9
JournalAnnals of the New York Academy of Sciences
Publication statusPublished - 2002


  • Flow cytometry
  • Hematologic malignancy
  • Immunophenotyping

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Multidimensional flow cytometry immunophenotyping of hematologic malignancy'. Together they form a unique fingerprint.

Cite this